Bicara Therapeutics (BCAX)'s 30-day implied volatility (IV30) was 67.6% at the close on November 6, 2026, down from 70.6% the day before, against a 52-week range of 34.4% to 98.5%. Its 20-day historical volatility was 80.2%.
Data as of November 6, 2026.